Association of Parasite Load Levels in Amniotic Fluid With Clinical Outcome in Congenital Toxoplasmosis

Imagem de Miniatura
Arquivos
art_YAMAMOTO_Association_of_Parasite_Load_Levels_in_Amniotic_Fluid_2017.PDF (1.31 MB)
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2017
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
TARGA, Lilia S.
SHIMOKAWA, Paulo T.
RODRIGUES, Jonatas C.
Citação
OBSTETRICS AND GYNECOLOGY, v.130, n.2, p.335-345, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: To correlate neonatal and infant clinical outcome with parasite load in amniotic fluid (AF). METHODS: We conducted a retrospective cohort study of 122 children whose mothers had toxoplasmosis during pregnancy. The children were monitored from birth to 12 months old. Stored AF samples were obtained at maternal diagnosis and tested by quantitative polymerase chain reaction. Gestational age at maternal infection, quantitative polymerase chain reaction results, neonatal anti-Toxoplasma gondii immunoglobulin (Ig) M, and clinical outcome at 12 months were correlated. RESULTS: Maternal infection occurred in 18 of 122 (14.7%) and 104 of 122 (85.2%) women in the first and second trimesters, respectively. At birth, IgM was present in 107 of 122 (87.7%) neonates and 36 (29.5%) were symptomatic. Of these, half occurred in the first and the other half in the second trimester and 6 of 36 had severe infections (16.7% of symptomatic, 4.9% of total), all infected in the first trimester. Parasite load levels were highly variable (median 35 parasites/mL, range 2-30,473). Logistic regression correlated symptomatic infection with gestational age (odds ratio [OR] 0.47, CI 0.31-0.73) and parasite load (OR 2.04, CI 1.23-3.37), but not with positive IgM (OR 6.81, CI 0.86-53.9). Negative correlations were found between gestational age and parasite load (rs -0.780, CI -0.843 to -0.696), gestational age and symptoms (rs -0.664, CI -0.755 to -0.547), but not gestational age and IgM (rs -0.136, CI -0.311 to 0.048). Parasite load levels distributed by percentile showed that all symptomatic patients appeared from the 75th percentile and all severe infections from the 95th percentile. Load rankings showed doubled the OR for each 20 parasite/mL increment. Parasite load was associated with symptomatic infections (area under the curve 0.959, CI 0.908-0.987) as well as gestational age (area under the curve 0.918, CI 0.855-0.960) and both parameters combined (area under the curve 0.969, CI 0.920-0.992). CONCLUSION: Parasite load in AF is associated with the clinical outcome in congenital toxoplasmosis, irrespective of gestational age at maternal infection.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/21976
Referências
  1. Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X
  2. Avci ME, 2016, J MATERN-FETAL NEO M, V29, P2073, DOI 10.3109/14767058.2015.1074998
  3. Bayley N., 1993, BAYLEY SCALES INFANT
  4. Brazilian Ministry of Health, 2012, HIGH RISK PREGN TECH, P115
  5. BURG JL, 1989, J CLIN MICROBIOL, V27, P1787
  6. CamargO M. E., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P117
  7. Costa JM, 2001, PRENATAL DIAG, V21, P85, DOI 10.1002/1097-0223(200102)21:2<85::AID-PD18>3.0.CO;2-1
  8. DAFFOS F, 1988, NEW ENGL J MED, V318, P271, DOI 10.1056/NEJM198802043180502
  9. DESMONTS G, 1974, NEW ENGL J MED, V290, P1110, DOI 10.1056/NEJM197405162902003
  10. Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765
  11. Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8
  12. Gratzl R, 2002, EUR J CLIN MICROBIOL, V21, P12, DOI 10.1007/s10096-001-0644-6
  13. Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8
  14. Costa JGL, 2013, J CLIN MICROBIOL, V51, P2766, DOI 10.1128/JCM.00982-13
  15. MCAULEY J, 1994, CLIN INFECT DIS, V18, P38
  16. Okay TS, 2009, CLINICS, V64, P171, DOI 10.1590/S1807-59322009000300004
  17. Pereira Ana Paula Esteves, 2013, BMC Res Notes, V6, P60, DOI 10.1186/1756-0500-6-60
  18. Petersen E, 2007, SEMIN FETAL NEONAT M, V12, P214, DOI 10.1016/j.siny.2007.01.011
  19. Peyron F, 2009, MEM I OSWALDO CRUZ, V104, P316, DOI 10.1590/S0074-02762009000200028
  20. Pomares C, 2016, J CLIN MICROBIOL, V54, P2448, DOI 10.1128/JCM.00487-16
  21. Robert-Gangneux F, 2017, J CLIN MICROBIOL, V55, P1369, DOI 10.1128/JCM.02379-16
  22. Robert-Gangneux F, 2014, J INFECTION, V68, pS125, DOI 10.1016/j.jinf.2013.09.023
  23. Rodrigues IMX, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-349
  24. Romand S, 2004, AM J OBSTET GYNECOL, V190, P797, DOI 10.1016/j.ajog.2003.09.039
  25. Sabin AB, 1941, J AMER MED ASSOC, V116, P801
  26. SCHOONDERMARKVANDEVEN E, 1994, ANTIMICROB AGENTS CH, V38, P1930
  27. Shimokawa PT, 2016, VIRULENCE, V7, P456, DOI 10.1080/21505594.2016.1150401
  28. Tan TG, 2010, VACCINE, V28, P3977, DOI 10.1016/j.vaccine.2010.03.028
  29. Teixeira LE, 2013, REV SOC BRAS MED TRO, V46, P584, DOI 10.1590/0037-8682-0095-2013
  30. Wallon M, 2013, CLIN INFECT DIS, V56, P1223, DOI 10.1093/cid/cit032
  31. Wallon M, 2010, OBSTET GYNECOL, V115, P727, DOI 10.1097/AOG.0b013e3181d57b09

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - LIM/48
Artigos e Materiais de Revistas Científicas - LIM/52